The presence of the BCR-ABL fusion gene can be detected through various laboratory techniques. Common methods include fluorescence in situ hybridization (FISH), which visualizes the genetic translocation, and polymerase chain reaction (PCR), which amplifies and identifies the specific genetic sequences. These diagnostic tests are crucial for confirming the presence of the Philadelphia chromosome in patients suspected of having CML or other related cancers.
